Dynavox Group (DYVOX) - Net Assets

Latest as of March 2026: Skr663.00 Million SEK ≈ $71.35 Million USD

Based on the latest financial reports, Dynavox Group (DYVOX) has net assets worth Skr663.00 Million SEK (≈ $71.35 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr2.53 Billion ≈ $271.84 Million USD) and total liabilities (Skr1.86 Billion ≈ $200.49 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Dynavox Group (DYVOX) tangible net worth to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr663.00 Million
% of Total Assets 26.25%
Annual Growth Rate 65.4%
5-Year Change 331.83%
10-Year Change N/A
Growth Volatility 127.51

Dynavox Group - Net Assets Trend (2019–2025)

This chart illustrates how Dynavox Group's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Dynavox Group to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Dynavox Group (2019–2025)

The table below shows the annual net assets of Dynavox Group from 2019 to 2025. For live valuation and market cap data, see Dynavox Group market cap and net worth.

Year Net Assets Change
2025-12-31 Skr602.40 Million
≈ $64.83 Million
+32.77%
2024-12-31 Skr453.70 Million
≈ $48.83 Million
+48.17%
2023-12-31 Skr306.20 Million
≈ $32.95 Million
+45.39%
2022-12-31 Skr210.60 Million
≈ $22.66 Million
+50.97%
2021-12-31 Skr139.50 Million
≈ $15.01 Million
+374.49%
2020-12-31 Skr29.40 Million
≈ $3.16 Million
0.00%
2019-12-31 Skr29.40 Million
≈ $3.16 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Dynavox Group's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1744.7% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings Skr640.10 Million 106.26%
Common Stock Skr500.00K 0.08%
Other Comprehensive Income Skr-38.20 Million -6.34%
Total Equity Skr602.40 Million 100.00%

Dynavox Group Competitors by Market Cap

The table below lists competitors of Dynavox Group ranked by their market capitalization.

Company Market Cap
Ncs Testing Technology Co Ltd
SHE:300797
$797.51 Million
Guilin Layn Natural Ingredients Corp
SHE:002166
$797.63 Million
PARATUS ENERGY SERVICES LTD
OL:PLSV
$798.00 Million
Liaoning Fu-An
SHG:603315
$798.36 Million
Zhejiang Meili High Technology Co Ltd
SHE:300611
$797.19 Million
Jiangyin Haida Rubber and Plastic Co Ltd Class A
SHE:300320
$797.09 Million
Fujian Guanfu Modern Household Wares Co Ltd
SHE:002102
$796.98 Million
Sanxiang Co Ltd
SHE:000863
$796.49 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Dynavox Group's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 453,700,000 to 602,400,000, a change of 148,700,000 (32.8%).
  • Net income of 165,700,000 contributed positively to equity growth.
  • New share issuances of 17,500,000 increased equity.
  • Other comprehensive income decreased equity by 61,299,999.
  • Other factors increased equity by 26,799,999.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Skr165.70 Million +27.51%
Share Issuances Skr17.50 Million +2.91%
Other Comprehensive Income Skr-61.30 Million -10.18%
Other Changes Skr26.80 Million +4.45%
Total Change Skr- 32.77%

Book Value vs Market Value Analysis

This analysis compares Dynavox Group's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 12.41x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 238.30x to 12.41x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 Skr0.29 Skr70.20 x
2020-12-31 Skr0.29 Skr70.20 x
2021-12-31 Skr1.39 Skr70.20 x
2022-12-31 Skr2.00 Skr70.20 x
2023-12-31 Skr2.79 Skr70.20 x
2024-12-31 Skr4.27 Skr70.20 x
2025-12-31 Skr5.66 Skr70.20 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Dynavox Group utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 27.51%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 6.72%
  • • Asset Turnover: 1.00x
  • • Equity Multiplier: 4.11x
  • Recent ROE (27.51%) is below the historical average (115.83%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 230.27% 7.45% 1.17x 26.47x Skr64.76 Million
2020 441.50% 14.50% 1.15x 26.47x Skr126.86 Million
2021 21.36% 3.42% 0.76x 8.22x Skr15.85 Million
2022 23.08% 4.00% 0.92x 6.28x Skr27.54 Million
2023 34.96% 6.45% 0.95x 5.70x Skr74.32 Million
2024 32.14% 7.39% 0.99x 4.40x Skr100.43 Million
2025 27.51% 6.72% 1.00x 4.11x Skr105.46 Million

Industry Comparison

This section compares Dynavox Group's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $349,884,118
  • Average return on equity (ROE) among peers: -50.93%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Dynavox Group (DYVOX) Skr663.00 Million 230.27% 2.81x $797.41 Million
ADDvise Group AB A (ADDV-A) $492.87 Million 16.45% 2.99x $4.23 Million
ADDvise Group B (ADDV-B) $492.87 Million 16.45% 2.99x $108.58 Million
AddLife AB (publ) (ALIF-B) $1.48 Billion 9.52% 1.22x $2.00 Billion
Biotage AB (BIOT) $502.65 Million 10.17% 0.23x $1.23 Billion
Bio-Works Technologies AB (BIOWKS) $22.41 Million -55.16% 0.10x $36.81 Million
Bonesupport Holding AB (BONEX) $124.31 Million -129.56% 0.58x $1.55 Billion
iZafe Group AB Series B (IZAFE-B) $11.69 Million -61.85% 0.46x $17.61 Million
Ortivus AB ser. A (ORTI-A) $17.21 Million -81.59% 1.14x $411.54K
Ortivus AB ser. B (ORTI-B) $8.75 Million -182.84% 2.99x $17.64 Million

About Dynavox Group

ST:DYVOX Sweden Medical Instruments & Supplies
Market Cap
$797.41 Million
Skr7.41 Billion SEK
Market Cap Rank
#10118 Global
#155 in Sweden
Share Price
Skr70.20
Change (1 day)
+0.29%
52-Week Range
Skr69.85 - Skr131.30
All Time High
Skr131.30
About

Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities. The company offers custom designed augmentative and alternative communication (AAC) solutions that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate on their own. Its commun… Read more